Related Experiment Video

Updated: Dec 13, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.6K

Course of a SARS-COV-2 pneumonia in a middle-aged male patient

Igor Alexander Harsch1, Marcin Skiba1, Thomas Heß2

  • 1Department of Internal Medicine Ii (Gastroenterology, Endocrinology), Thuringia Clinic "Georgius Agricola", Saalfeld/Saale, Germany.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|August 1, 2020
PubMed

Insights

A 57-year-old man developed moderate COVID-19 pneumonia despite no risk factors. This early SARS-CoV-2 case highlights that good health doesn't always prevent severe infection.

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • The World Health Organization declared SARS-CoV-2 infection a global pandemic.
  • While severe cases and fatalities are more common in the elderly with comorbidities, younger individuals without risk factors can also develop severe SARS-CoV-2 pneumonia.

Observation:

  • A 57-year-old man, with no underlying health conditions, contracted SARS-CoV-2 pneumonia following a skiing trip to Northern Italy.
  • Other travel companions experienced only flu-like symptoms.
  • Radiological findings were significant, yet the patient's condition improved with supportive care.

Findings:

  • This case represents an early SARS-CoV-2 infection in Germany.
  • The patient's younger age and lack of comorbidities likely contributed to a positive disease course.
  • Despite a good health status, the individual acquired a moderately severe SARS-CoV-2 infection.

Implications:

  • Early SARS-CoV-2 cases in diverse populations are crucial for understanding disease spectrum.
  • The findings suggest that even healthy individuals can experience significant illness from SARS-CoV-2.
  • This case underscores the unpredictable nature of SARS-CoV-2 infection severity.
Keywords:
SARS-CoV-2SARSadrenocorticotrophic axisprolactintransmissiondetectionliver injurypneumonia

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.7K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

756

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
678
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
596
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
601
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
862